THE LATEST
NEWS
AND
RESEARCH

Jan 2018

The NSW Government has launched the country’s first cannabis medicines hotline. The hotline – part of a $21 million investment in cannabis medicines research – will simplify and speed up access for doctors whose patients may benefit from this type of treatment. The service will provide guidance for the use of cannabis medicines, including advice on clinical management, available medicines, and dosage information.

LEARN MORE >
    1 of
    MORE NEWS

    Olivia Newton-John, who is battling cancer for the third time, has revealed that following radiation therapy she been using cannabis oil to treat her cancer symptoms, such as pain.

    READ MORE >

    Despite medicinal cannabis being decriminalized across the country, due to uneven legislation across states governing the prescription and use of medical cannabis, it remains difficult to source.

    READ MORE >

    Sydney businessman Barry Lambert, who was found guilty of possession and cultivation of cannabis in 2017, claims that hemp extract was the only thing that helped to stop his granddaughter’s seizures.

    READ MORE >

    Latest data shows that since it became easier for doctors to prescribe medicinal cannabis in New South Wales, 322 applications have been approved.

    READ MORE >

    A study conducted by researchers from The Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney found that almost two thirds of 640 Australian GPs surveyed have had patients ask about the drug.

    READ MORE >

    A study conducted by researchers from The Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney found that almost two thirds of 640 Australian GPs surveyed have had patients ask about the drug.

    READ MORE >

    TEN NEW MEDICINAL CANNABIS CLINICS TO OPEN IN MELBOURNE THIS […]

    READ MORE >

    AUSTRALIAN PATIENTS TRAVELLING OVERSEAS FOR MEDICINAL CANNABIS Eighteen months on from […]

    READ MORE >

    MEDICINAL CANNABIS EXPORTS APPROVED BY FEDERAL GOVERNMENT Following an extensive […]

    READ MORE >

    MEDICINAL CANNABIS IN AUSTRALIA: HOW LEGAL IS IT? Following the […]

    READ MORE >

    FIRST AUSTRALIAN TRIAL TO EXPLORE EFFECTS OF MEDICINAL CANNABIS ON […]

    READ MORE >

    VICTORIAN CHILDREN TO ACCESS MEDICAL CANNABIS IN EPILEPSY TRIAL Twenty-nine […]

    READ MORE >

    UNIFIED ACCESS SYSTEM FOR MEDICAL CANNABIS NEEDED Blue Mountains GP […]

    READ MORE >

    The Commonwealth Department of Health, in conjunction with state and territory governments, has helped coordinate the development new clinical guidance documents for medicinal cannabis products.

    READ MORE >

    MEDICINAL CANNABIS ACCESS REGULATIONS ‘UNWORKABLE’ An Adelaide GP has criticised […]

    READ MORE >

    ADMINISTRATIVE OBSTACLES SLOW MEDICINAL CANNABIS UPTAKE IN NSW In the […]

    READ MORE >

    LUCY HASLAM STRIVES TO IMPROVE MEDICINAL CANNABIS ACCESS FOR PATIENTS […]

    READ MORE >

    RACGP PRESIDENT CRITICISES MEDICAL CANNABIS REGULATION The Royal College of […]

    READ MORE >

    FIRST TASMANIANS APPROVED UNDER NEW SCHEME TO USE MEDICINAL CANNABIS […]

    READ MORE >

    Liberal Democrats Senator David Leyonhjelm has called on the federal government to ‘quit dithering’ and cut the red tape preventing thousands of Australians suffering chronic pain from accessing medicinal cannabis.

    READ MORE >

    NSW GOVERNMENT ACCUSED OF DELAYING ACCESS TO MEDICAL CANNABIS Shadow […]

    READ MORE >

    QUEENSLAND LEADS WITH WORLD-FIRST MEDICINAL CANNABIS TRIAL A Queensland trial […]

    READ MORE >

    Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla at massa in neque egestas pellentesque. Donec nec urna sodales, bibendum justo vel, porta libero. Praesent id libero eros. Nullam elementum, ipsum ac hendrerit suscipit, risus mi feugiat erat, quis faucibus eros velit et turpis.

    READ MORE >
    RESEARCH
    Dec 2018

    The results show that medicinal cannabis has a reasonable safety profile and can help with pain management, quality of life and cognitive function.

    READ MORE >
    Nov 2018

    This review of 49 studies assesses the use of medicinal cannabis for anxiety-related disorders. The available evidences demonstrates there is a potential benefit of cannabinoids in reducing anxiety behaviors relevant to disorders such as PTSD, GAD, PD, OCD, and SAD, with no anxiogenic effects. The authors emphasise the potential value and need for further study of CBD in the treatment of anxiety disorders.

    READ MORE >
    Nov 2018

    The review of 24 reports evaluates the use of medicinal cannabis for psychiatric, movement and neurodegenerative disorders. The available evidences suggest there is a potential benefit of cannabinoids for those diseases however further research is required to confirm its efficacy. 

    READ MORE >
    Oct 2018

    A double-blind, placebo-controlled trial on 120 children and young adults with the Dravet syndrome and drug-resistant seizures shows that cannabidiol reduces the frequency of convulsive seizures.

    READ MORE >
    Aug 2018

    Systematic review of 13 studies shows that cannabis-based medicinal extracts may provide effective pain relief to patients suffering with chronic nonmalignant neuropathic pain, especially with conditions that are resistant to other treatments.

    READ MORE >
    Aug 2018

    The study collected data from 65 families to explore their experiences with medicinal cannabis to help treat their children’s epilepsy.

    READ MORE >
    Jun 2018

    Review synthesises findings from high quality systematic reviews

    READ MORE >
    May 2018

    The review of preclinical studies outlining the role of cannabinoids in the modulation of headache pathogenesis.

    READ MORE >
    Mar 2018

    Review synthesises findings from high quality systematic reviews

    READ MORE >
    Mar 2018

    Study assessing the efficacy and safety of cannabidiol as an add-on anticonvulsant

    READ MORE >
    Feb 2018

    A systematic review and meta-analysis on the efficacy, tolerability, and safety of cannabinoids in palliative medicine.

    READ MORE >

    We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

    LEARN ABOUT ANTG HERE >